Clinical Renal Pharmacology and Therapeutics.

Authors :: Trimarchi, Hernan
Schiel, A.
Freixas, E.
Dieleman, J. P.
Sturkenboom, M. C. J. M.
Jambroes, M.
Knoll, Greg A.
Sahgal, A.
Nair, R. C.
Butler, J. V.
McAvoy, H.
McEnroy, D.
Hu, Y.
Carpenter, J. P.
Cheung, A. T.
Kincaid-Smith, Priscilla
Fairley, K.
Packham, D.
Elian, K. M.
Source :: Kidney; Jan/Feb2003, Vol. 12 Issue 1, p42, 7p
Publication Year :: 2003
Abstract: Presents several studies on clinical renal pharmacology and therapeutics. Risk factors for the urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate; Risk of hyperkalemia in hemodialysis patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers; Effects of spironolactone on potassium homeostasis in elderly patients with congestive heart failure.